ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,027 | -1.5% | 16,355 | +11.6% | 0.00% | 0.0% |
| Q2 2023 | $450,584 | -12.1% | 14,653 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $512,646 | -64.1% | 14,230 | -60.6% | 0.00% | -33.3% |
| Q4 2022 | $1,426,090 | +233.2% | 36,080 | +238.1% | 0.00% | +50.0% |
| Q3 2022 | $428,000 | -2.1% | 10,671 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $437,000 | +54.4% | 10,412 | +42.8% | 0.00% | +100.0% |
| Q1 2022 | $283,000 | -34.6% | 7,293 | -33.0% | 0.00% | -50.0% |
| Q4 2021 | $433,000 | +10.2% | 10,891 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $393,000 | -25.0% | 10,868 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | -2.1% | 12,791 | +4.3% | 0.00% | 0.0% |
| Q1 2021 | $535,000 | +24.1% | 12,265 | +42.2% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | – | 8,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |